Market Overview:
The global postoperative pain therapeutics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic pain, rising geriatric population, and growing demand for postoperative pain relief drugs. Based on type, the global postoperative pain therapeutics market is segmented into oral analgesics, intramuscular analgesics, intravenous analgesics, and others (including topical analgesics and rectal formulations). Oral analgesics are further sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids. Intravenous analgesics are further sub-segmented into local anesthetics and general anesthetics. Based on application, the global postoperative pain therapeutics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others (including clinics/outpatient settings). Geographically speaking North America dominates the global postoperative pain therapeutics market followed by Europe due to high prevalence of chronic diseases in these regions coupled with increasing number of surgical procedures performed each year.
Product Definition:
Postoperative pain is a type of pain that can occur after surgery. It may be caused by the surgery itself, or by the medications used to numb and relax you during the procedure. Postoperative pain may also occur if there is inflammation or swelling in the surgical area. Treatment for postoperative pain usually includes medications such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and acetaminophen.
Oral:
Oral is a form of drug delivery route which involves the use of medications administered in the mouth. The most common routes of oral administration include tablets, capsules, syrups and topical (transdermal). Other forms such as lozenges, pellets and drops also exist but are less popular.
The factors that propel growth factor for this market include increasing prevalence of chronic diseases like cancer & diabetes along with rising geriatric population base that has multiple medical conditions.
Intramuscular:
Intramuscular is a generic name for drugs that are injected into muscle. Intramuscular drug delivery system has been used in pain therapeutics since the beginning of recorded history. The intramuscular route of administration offers several advantages such as it allows rapid onset of action, it can be repeated if necessary and there is very little chance that the drug will get carried away from its target site (if any).
Application Insights:
The others segment held the largest share of the global postoperative pain therapeutics market in 2017. This is due to factors such as increasing prevalence of chronic diseases and rising geriatric population across the globe. The hospital pharmacies segment is expected to grow at a lucrative rate over the forecast period owing to growing awareness about various benefits associated with it, such as providing faster relief from pain and anxiety caused by surgery or trauma.
The online pharmacies are also expected to witness significant growth over the forecast period due to easy access provided through internet for purchasing medicines 24*7*365 via internet banking transactions, e-commerce platforms or mobile applications without having physical contact with any other person including pharmacist or doctor. Moreover, these online pharmacies offer home delivery services which further boost their revenue generation capabilities on daily basis during working hours when patients need medication most often i.e.
Regional Analysis:
North America dominated the global postoperative pain therapeutics market in 2017. The region is expected to maintain its position during the forecast period as well. This can be attributed to increasing awareness about chronic pain management, rising number of surgical procedures, and growing demand for opioid-based postoperative analgesics and other drugs. In addition, favorable reimbursement policies are also anticipated to propel growth during the forecast period. For instance, healthcare payers such as Medicare Part A & B covers around 80% of medical costs after a surgery or an outpatient clinic appointment within 1 year of discharge from hospital or clinic respectively (U.S.).
Asia Pacific is expected to grow at a lucrative rate over the next few years owing to increasing prevalence of chronic diseases coupled with rising patient awareness levels regarding various treatment options available for them in this region especially after discharge from hospitals/clinics/surgeries etc.
Growth Factors:
- Increasing incidence of surgery: The global incidence of surgery is increasing due to the rise in the number of chronic diseases, such as cancer, cardiovascular diseases, and orthopedic problems. This is expected to drive the demand for postoperative pain therapeutics products.
- Growing geriatric population: The global geriatric population is growing at a rapid pace and this is expected to increase the demand for postoperative pain therapeutics products, as older patients are more susceptible to developing chronic pain conditions after surgery.
- Technological advancements: There has been a significant advancement in postoperative pain management therapies in recent years with the advent of novel drug delivery technologies and devices that offer better patient outcomes. This is likely to boost the growth of the postoperative pain therapeutics market over the forecast period.
- Rising healthcare expenditure: There has been a significant increase in healthcare expenditure across developed and emerging markets in recent years due to rising awareness about treatment options for various medical conditions and an aging population base requiring more complex treatments such as surgeries.. This is anticipated to spur growth prospects forthepostoperativepaintherapeuticmarketin these regions duringthe forecast period . 5) Emerging markets offer untapped potential: Thepostoperativepaintherapeuticmarket offers substantialgrowth potentialin emerging marketsdue tobroadeningaccessibilitytotreatmentoptionsandgrowingawarenessabouttheseproductsamongpatientsandhealthcareprofessionals
Scope Of The Report
Report Attributes
Report Details
Report Title
Postoperative Pain Therapeutics Market Research Report
By Type
Oral, Intramuscular, Intravenous, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Companies
Mallinckrodt Pharmaceuticals, Pacira BioSciences, Trevena, Heron Therapeutics, Pfizer, Teva Pharmaceutical Industries, Novartis, Camarus, Eli Lilly, Bayer AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Postoperative Pain Therapeutics Market Report Segments:
The global Postoperative Pain Therapeutics market is segmented on the basis of:
Types
Oral, Intramuscular, Intravenous, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mallinckrodt Pharmaceuticals
- Pacira BioSciences
- Trevena
- Heron Therapeutics
- Pfizer
- Teva Pharmaceutical Industries
- Novartis
- Camarus
- Eli Lilly
- Bayer AG
Highlights of The Postoperative Pain Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Intramuscular
- Intravenous
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postoperative Pain Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Postoperative pain therapeutics is a group of medications used to manage postoperative pain. These medications can be administered either before or after surgery.
Some of the major companies in the postoperative pain therapeutics market are Mallinckrodt Pharmaceuticals, Pacira BioSciences, Trevena, Heron Therapeutics, Pfizer, Teva Pharmaceutical Industries, Novartis, Camarus, Eli Lilly, Bayer AG.
The postoperative pain therapeutics market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Postoperative Pain Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Postoperative Pain Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Postoperative Pain Therapeutics Market - Supply Chain
4.5. Global Postoperative Pain Therapeutics Market Forecast
4.5.1. Postoperative Pain Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Postoperative Pain Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Postoperative Pain Therapeutics Market Absolute $ Opportunity
5. Global Postoperative Pain Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Postoperative Pain Therapeutics Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Intramuscular
5.3.3. Intravenous
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Postoperative Pain Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Postoperative Pain Therapeutics Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Postoperative Pain Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Postoperative Pain Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Postoperative Pain Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Postoperative Pain Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Postoperative Pain Therapeutics Demand Share Forecast, 2019-2026
9. North America Postoperative Pain Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Postoperative Pain Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Postoperative Pain Therapeutics Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Postoperative Pain Therapeutics Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Intramuscular
9.7.3. Intravenous
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Postoperative Pain Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Postoperative Pain Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Postoperative Pain Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Postoperative Pain Therapeutics Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Postoperative Pain Therapeutics Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Intramuscular
10.7.3. Intravenous
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Postoperative Pain Therapeutics Demand Share Forecast, 2019-2026
11. Europe Postoperative Pain Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Postoperative Pain Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Postoperative Pain Therapeutics Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Postoperative Pain Therapeutics Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Intramuscular 11.7.3. Intravenous
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Postoperative Pain Therapeutics Demand Share, 2019-2026
12. Asia Pacific Postoperative Pain Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Postoperative Pain Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Postoperative Pain Therapeutics Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Postoperative Pain Therapeutics Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Intramuscular
12.7.3. Intravenous
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Postoperative Pain Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Postoperative Pain Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Postoperative Pain Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Postoperative Pain Therapeutics Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Postoperative Pain Therapeutics Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Intramuscular
13.7.3. Intravenous
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Postoperative Pain Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Postoperative Pain Therapeutics Market: Market Share Analysis
14.2. Postoperative Pain Therapeutics Distributors and Customers
14.3. Postoperative Pain Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mallinckrodt Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pacira BioSciences
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Trevena
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Heron Therapeutics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva Pharmaceutical Industries
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novartis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Camarus
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Eli Lilly
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bayer AG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
